Related Experiment Video
Updated: Jan 20, 2026
Pneumonia V: Nursing management and Prevention
Delivering vaccines for the prevention of pneumonia - programmatic and financial issues
Diana C Otczyk1, Allan W Cripps1
1School of Medicine, Griffith Health Institute, Griffith University, Gold Coast Campus, Queensland, 4222 Australia.
Insights
Vaccines significantly reduce childhood pneumonia, a leading cause of death. Continued global efforts are crucial, but challenges like access and funding must be overcome to improve child survival rates.
Area of Science:
- Pediatrics
- Immunology
- Public Health
Background:
- Pneumonia is a primary cause of death in children under five globally.
- Vaccines against key bacterial pathogens (Haemophilus influenzae type b, Streptococcus pneumoniae) and predisposing diseases (measles, pertussis) are vital.
- Global initiatives have increased vaccine access in developing nations.
Purpose of the Study:
- To highlight the importance of vaccines in preventing childhood pneumonia.
- To emphasize the need to scale up pneumonia interventions as per the Global Action Plan for the Prevention and Control of Pneumonia (GAPP).
- To identify challenges hindering vaccine implementation and advocate for increased global awareness.
Main Methods:
- Review of existing literature on childhood pneumonia and vaccine impact.
- Analysis of global vaccination initiatives and coverage improvements.
- Identification of barriers to vaccine implementation in low-resource settings.
Main Results:
- Significant improvements in global vaccine coverage have been observed over the last decade.
- Vaccines against Haemophilus influenzae type b and Streptococcus pneumoniae are available and effective.
- Despite progress, challenges such as access, funding, and political commitment impede widespread vaccine implementation.
Conclusions:
- Global immunization holds promise for improving child survival by reducing pneumonia.
- Addressing challenges like access for marginalized populations, sustainable funding, and political will is critical for effective vaccine rollout.
- Increased global awareness of pneumonia's impact is needed to drive action and improve child health outcomes.
Abstract:
Pneumonia is the leading cause of morbidity and mortality in children younger than 5 years. Vaccines are available against the main bacterial pathogens Haemophilus influenzae type b and Streptococcus pneumoniae. There are also vaccines against measles and pertussis; diseases that can predispose a child to pneumonia. Partners such as the Global Alliance for Vaccines and Immunisation (GAVI), the Hib Initiative, the Accelerated Development and Introduction Plan for pneumococcal vaccines and the Measles Initiative, have accelerated the introduction of vaccines into developing countries. Whilst significant improvements in vaccine coverage have occurred globally over the past decade, there still remains an urgent need to scale-up key pneumonia protection and treatment interventions as identified in the Global Action Plan for the Prevention and Control of Pneumonia (GAPP). There is promise that global immunisation will continue to improve child survival. However, there are several challenges to vaccine implementation that must first be addressed, including: a lack of access to under-served and marginalised populations; inadequate planning and management; a lack of political commitment; weak monitoring and surveillance programmes and assured sustainable finance and supply of quality vaccines. There is an urgent need to increase global awareness of the devastation that pneumonia brings to the worlds poorest communities.
Related Concept Videos
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:51Vaccinations
08:52Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
01:27Ethical Issues
Ethical Concerns in Healthcare:
06:17Expression and Purification of Virus-like Particles for Vaccination
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii